HHIPL2

Model summary

A soluble neuronal assembly factor that resides predominantly in the endoplasmic reticulum lumen and is partially secreted. It uses an N-terminal ligand-binding module and a six-bladed beta-propeller scaffold to organize lumenal protein assemblies that shepherd synaptic organizers through the secretory pathway. By stabilizing multiprotein complexes that shape synapse architecture and trophic signaling, it promotes proper synaptic organization and protects neurons from apoptotic pathways.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture.

   An N-terminal IPR018143 Folate receptor-like domain spans residues 57–165, followed by an extended C-terminal beta-propeller core defined by three concordant signatures: IPR011042 Six-bladed beta-propeller, TolB-like (homologous_superfamily) from residues 205–597, IPR011041 Soluble quinoprotein glucose/sorbosone dehydrogenase, beta-propeller domain superfamily from residues 208–583, and the embedded IPR012938 Glucose/Sorbosone dehydrogenase domain from residues 216–544. This ordered layout—an N-terminal ligand-binding module feeding into a six-bladed beta-propeller scaffold—creates a soluble, lumenal binding platform rather than a membrane anchor or cytosolic enzyme. The beta-propeller fold is a versatile interaction hub that stabilizes multiprotein assemblies and frequently mediates calcium- and pH-tuned recognition in secretory pathway compartments.

2. 02

   This architecture dictates molecular function as multivalent binding rather than catalysis.

   The folate receptor-like domain provides a high-affinity binding surface for small-molecule or protein ligands, while the TolB-like beta-propeller supplies a rigid, solvent-exposed platform for assembling complexes. Together, these features cause robust protein binding, aligning with GO:0005515 protein binding as the primary molecular function.

3. 03

   From function to process, a lumenal binding scaffold in neurons naturally interfaces with pathways that depend on precise secretory trafficking and extracellular matrix handling.

   A beta-propeller-centered assembly platform in the endoplasmic reticulum (ER) and early secretory route can organize synaptic organizers and adhesion modules that shape synapse architecture, supporting GO:0050808 synapse organization. By stabilizing secretory cargo and synaptic organizers, the same scaffold reduces pro-death signaling cascades in neurons, providing a mechanistic basis for GO:0043524 negative regulation of neuron apoptotic process. The causal chain runs from lumenal complex assembly to proper delivery of synaptic and trophic factors, which in turn suppresses apoptosis.

4. 04

   Cellular location follows directly from the soluble, secretory-pathway architecture.

   The absence of transmembrane segments and the presence of lumen-facing binding domains point to a soluble residency within the ER and downstream secretory compartments. This supports localization to the GO:0005788 endoplasmic reticulum lumen and explains the experimentally observed secreted pool: a fraction likely traffics onward to the extracellular space where it can modulate synaptic environments.

5. 05

   Mechanistically, I hypothesize that the protein acts as a lumenal organizer that nucleates calcium-tuned assemblies of synaptic adhesion molecules and secretory chaperones.

   In the ER lumen, the folate receptor-like domain captures ligands or partially folded clients, while the beta-propeller stabilizes higher-order complexes that shepherd synaptic organizers through quality control. This assembly role would couple ER homeostasis to synaptic maturation and survival pathways. Likely partners include ER chaperones and lectins (e.g., BiP/HSPA5, calnexin/calreticulin), calcium-binding ER luminal proteins (e.g.,GRP78), and neuronal adhesion/synaptogenic factors that transit the secretory pathway (e.g., neurexins/neuroligins, amyloid precursor-like cargo). Through these interactions, the protein’s binding architecture enforces synapse organization and buffers neurons against apoptosis.